Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: J Neuroimmune Pharmacol. 2015 Apr 8;10(3):425–434. doi: 10.1007/s11481-015-9605-1

Figure 2B.

Figure 2B

Variables of importance in projection (VIP) scores for the most relevant metabolites in PLS-DA. The panel to the right indicates relative effect direction in the two groups.